Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 6/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | PRKCG | P05129 | 1/20 | 0.38 |
| ▸ | PRKCB | P05771 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCH | P24723 | 1/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.38 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.38 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22224178 | 1.00 | TYR (0.41) | TYRL3MBTL1AMY1APRKD3PRKCG | |
| SCHEMBL13126159 | 1.00 | TYR (0.41) | TYRL3MBTL1AMY1APRKD3PRKCG | |
| SCHEMBL10047647 | 0.94 | TYR (0.48) | TYRAMY1AALDH1A1LGALS8LGALS3 | |
| SCHEMBL17341181 | 0.94 | TYR (0.48) | TYRAMY1AALDH1A1LGALS8LGALS3 | |
| SCHEMBL16234072 | 0.90 | AMY2A (0.45) | TYRL3MBTL1AMY1APRKD3PRKCG | |
| SCHEMBL19668934 | 0.90 | LGALS8 (0.46) | TYRAMY1ALGALS8 | |
| SCHEMBL13161605 | 0.90 | LGALS8 (0.46) | TYRAMY1ALGALS8 | |
| SCHEMBL13716367 | 0.90 | AMY2A (0.45) | TYRL3MBTL1AMY1APRKD3PRKCG | |
| SCHEMBL24943577 | 0.87 | L3MBTL1 (0.49) | TYRL3MBTL1PRKD3PRKCGPRKCB | |
| SCHEMBL14690973 | 0.87 | L3MBTL1 (0.49) | TYRL3MBTL1PRKD3PRKCGPRKCB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3367820-B1 | PREPARATION OF MODIFIED CELLULOSE AND ITS DERIVATIVES | INNOTECH MAT LLC (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20210403642-A1 | AZLACTONE FUNCTIONALIZED SUBSTRATES FOR CONJUGATION OF BIOMOLECULES | ROBERT BOSCH GMBH (DE) | 2021-12-30 | — | — | US | disclosed |
| US-10813377-B2 | Preparation of modified cellulose and its derivatives | INNOTECH MATERIALS, LLC (US) | 2020-10-27 | — | — | US | disclosed |
| US-9832998-B2 | Antiviral compositions | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2017-12-05 | — | — | US | disclosed |
| US-20170342211-A1 | AZLACTONE FUNCTIONALIZED SUBSTRATES FOR CONJUGATION OF BIOMOLECULES | ROBERT BOSCH GMBH (DE) | 2017-11-30 | — | — | US | disclosed |
| WO-2017075417-A1 | PREPARATION OF MODIFIED CELLULOSE AND ITS DERIVATIVES | INNOTECH MATERIALS, LLC (US) | 2017-05-04 | — | — | WO | disclosed |
| US-20150196032-A1 | ANTIVIRAL COMPOSITIONS | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2015-07-16 | — | — | US | disclosed |
| US-8999316-B2 | Antiviral compounds | PACE UNIVERSITY (US) | 2015-04-07 | — | — | US | disclosed |
| US-8329155-B2 | Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof | MONTANA STATE UNIVERSITY (US) | 2012-12-11 | — | — | US | disclosed |
| US-20090196847-A1 | QUATERNARY AMMONIUM FUNCTIONALIZED GLYCODENDRIMERS, METHODS FOR THE PRODUCTION AND USE THEREOF | NIH | 2009-08-06 | — | — | US | disclosed |
| US-20080299070-A1 | Antiviral Compounds | LONG ISLAND UNIVERSITY | 2008-12-04 | — | — | US | disclosed |
| US-7285286-B2 | Antimicrobial surfaces | LONG ISLAND UNIVERSITY (US) | 2007-10-23 | — | — | US | disclosed |
| US-7241453-B2 | Antimicrobial surfaces | LONG ISLAND UNIVERSITY (US) | 2007-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299070-A1 | Antiviral Compounds | EIF2AK2, MAVS, SARS1 | TYR 3355/4885L3MBTL1 1173/4885AMY1A 4010/4885 |
| US-20090196847-A1 | QUATERNARY AMMONIUM FUNCTIONALIZED GLYCODENDRIMERS, METHODS FOR THE PRODUCTION AND USE THEREOF | ZYX, FUT5, B3GNT2 | TYR 3883/4885L3MBTL1 4554/4885AMY1A 2193/4885 |
| US-20150196032-A1 | ANTIVIRAL COMPOSITIONS | EIF2AK2, MAVS, SARS1 | TYR 3195/4885L3MBTL1 1308/4885AMY1A 4007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.